chr16-50290458-A-G
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_001114.5(ADCY7):āc.173A>Gā(p.Asp58Gly) variant causes a missense, splice region change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000663 in 1,613,776 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/23 in silico tools predict a benign outcome for this variant. 3/3 splice prediction tools predict no significant impact on normal splicing. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001114.5 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 0 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ADCY7 | NM_001114.5 | c.173A>G | p.Asp58Gly | missense_variant, splice_region_variant | 3/26 | ENST00000673801.1 | NP_001105.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ADCY7 | ENST00000673801.1 | c.173A>G | p.Asp58Gly | missense_variant, splice_region_variant | 3/26 | NM_001114.5 | ENSP00000501053 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000461 AC: 7AN: 151964Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000201 AC: 5AN: 248788Hom.: 0 AF XY: 0.0000149 AC XY: 2AN XY: 134674
GnomAD4 exome AF: 0.0000684 AC: 100AN: 1461812Hom.: 1 Cov.: 31 AF XY: 0.0000646 AC XY: 47AN XY: 727204
GnomAD4 genome AF: 0.0000461 AC: 7AN: 151964Hom.: 0 Cov.: 32 AF XY: 0.0000404 AC XY: 3AN XY: 74246
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 20, 2023 | The c.173A>G (p.D58G) alteration is located in exon 2 (coding exon 2) of the ADCY7 gene. This alteration results from a A to G substitution at nucleotide position 173, causing the aspartic acid (D) at amino acid position 58 to be replaced by a glycine (G). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at